Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis Patients”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02483234
What this trial is testing

Psoriasis-Arthritis & Bone Program

Who this might be right for
PsoriasisPsoriatic Arthritis
University of Erlangen-Nürnberg Medical School 40
Post-approval studies (Phase 4)Study completedNCT03440736
What this trial is testing

Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome

Who this might be right for
PsoriasisMetabolic Syndrome
Novartis Pharmaceuticals 781
Large-scale testing (Phase 3)Study completedNCT02065713
What this trial is testing

Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients

Who this might be right for
Psoriatic Arthritis
Instituto de Medicina Molecular João Lobo Antunes 44
Not applicableStudy completedNCT00407979
What this trial is testing

Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis

Who this might be right for
Atopic DermatitisPsoriasis
National Institute of Allergy and Infectious Diseases (NIAID) 80
Post-approval studies (Phase 4)UnknownNCT01223976
What this trial is testing

Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis

Who this might be right for
TuberculosisPsoriasis
Tel-Aviv Sourasky Medical Center 150
Testing effectiveness (Phase 2)Study completedNCT01208090
What this trial is testing

ACT-128800 in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Actelion 326
Early research (Phase 1)Study completedNCT02097173
What this trial is testing

Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen

Who this might be right for
Psoriasis
medac GmbH 35
Not applicableStudy completedNCT03925441
What this trial is testing

Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in Korea

Who this might be right for
Psoriasis
AbbVie 2
Not applicableStudy completedNCT02274363
What this trial is testing

Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type Psoriasis

Who this might be right for
PsoriasisPlaque
Janssen Pharmaceutica 1,131
Testing effectiveness (Phase 2)Ended earlyNCT06380907
What this trial is testing

ZL-1102 in Patients With Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Zai Lab (Hong Kong), Ltd. 65
Testing effectiveness (Phase 2)Ended earlyNCT02243787
What this trial is testing

Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Covagen 24
Post-approval studies (Phase 4)Study completedNCT00493324
What this trial is testing

Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Astellas Pharma Inc 43
Post-approval studies (Phase 4)Study completedNCT00581100
What this trial is testing

Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis

Who this might be right for
Nail PsoriasisPlaque Psoriasis
Wyeth is now a wholly owned subsidiary of Pfizer 136
Large-scale testing (Phase 3)Study completedNCT01008995
What this trial is testing

The Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 322
Not applicableStudy completedNCT01202565
What this trial is testing

Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 506
Not applicableLooking for participantsNCT07683065
What this trial is testing

Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD

Who this might be right for
Plaque PsoriasisMetabolic Dysfunction-Associated Steatotic Liver Disease
Novartis Pharmaceuticals 150
Not applicableActive Not RecruitingNCT06952465
What this trial is testing

A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 2,000
Testing effectiveness (Phase 2)Study completedNCT02933502
What this trial is testing

Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product

Who this might be right for
Scalp Psoriasis
Sun Pharmaceutical Industries, Inc. 3
Large-scale testing (Phase 3)Study completedNCT04632927
What this trial is testing

Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 119
Early research (Phase 1)Study completedNCT03073213
What this trial is testing

Ixekizumab in Chinese Participants With Psoriasis Vulgaris

Who this might be right for
Psoriasis
Eli Lilly and Company 32
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation